Literature DB >> 10580207

Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage.

S van den Hof1, G A Berbers, H E de Melker, M A Conyn-van Spaendonck.   

Abstract

Serum antibodies against measles were measured in the Dutch general population and in municipalities with low vaccine coverage, where religious groups that refuse vaccination are clustered sociogeographically. The results suggest that wild measles virus may still circulate in municipalities with low vaccine coverage; the circulation in the general population seems to have decreased significantly right after the introduction of mass vaccination. The overall prevalence in the general population was high (95.7%, 95% confidence limits 95.3-96.2%); the seroprevalence in the age groups offered two vaccinations (91.7%, 95% confidence limits 89.4-94.0%) was lower than the level believed to be necessary for the elimination of measles. Protective levels of maternal antibodies in newborns have waned several months before the first vaccination is scheduled.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580207     DOI: 10.1016/s0264-410x(99)00348-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

1.  Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus.

Authors:  Gaby P Smits; Pieter G van Gageldonk; Leo M Schouls; Fiona R M van der Klis; Guy A M Berbers
Journal:  Clin Vaccine Immunol       Date:  2012-01-11

2.  Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization.

Authors:  Rik L de Swart; Selma Yüksel; Albert D M E Osterhaus
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  Seroprevalence of measles among Norwegian military conscripts in 2004.

Authors:  K Vainio; H H Samdal; G Anestad; D H Skutlaberg; K T Bransdal; R Mundal; I Aaberge
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-03       Impact factor: 3.267

4.  Measles outbreak in a community with very low vaccine coverage, the Netherlands.

Authors:  S van den Hof; C M Meffre; M A Conyn-van Spaendonck; F Woonink; H E de Melker; R S van Binnendijk
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

5.  Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage.

Authors:  Sandra Waaijenborg; Susan J M Hahné; Liesbeth Mollema; Gaby P Smits; Guy A M Berbers; Fiona R M van der Klis; Hester E de Melker; Jacco Wallinga
Journal:  J Infect Dis       Date:  2013-05-08       Impact factor: 5.226

6.  Antibody levels after regular childhood vaccinations in the immunological screening of children with recurrent otitis media.

Authors:  Selma P Wiertsema; Elisabeth A M Sanders; Reinier H Veenhoven; Niels Van Heerbeek; Susan van den Hof; Guy A M Berbers; Ger T Rijkers
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

7.  Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013.

Authors:  Chao Ma; Fangjun Li; Xiang Zheng; Hong Zhang; Mengjuan Duan; Yanhua Yang; Lixin Hao; Qiru Su; Lance Rodewald; Bosong Guo; Shanliang Xiao; Huaqing Wang; Li Li; Junhua Li; Huiming Luo; Lidong Gao
Journal:  BMC Infect Dis       Date:  2015-01-22       Impact factor: 3.090

8.  High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands.

Authors:  L Mollema; G P Smits; G A Berbers; F R Van Der Klis; R S Van Binnendijk; H E De Melker; S J M Hahné
Journal:  Epidemiol Infect       Date:  2013-08-06       Impact factor: 4.434

9.  Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands.

Authors:  M van Wijhe; A D Tulen; H Korthals Altes; S A McDonald; H E de Melker; M J Postma; J Wallinga
Journal:  Epidemiol Infect       Date:  2018-03-14       Impact factor: 4.434

10.  Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks.

Authors:  Gaby Smits; Liesbeth Mollema; Susan Hahné; Hester de Melker; Irina Tcherniaeva; Sandra Waaijenborg; Rob van Binnendijk; Fiona van der Klis; Guy Berbers
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.